Department Digestive Surgery, CHU Rennes, Pontchaillou Hospital, Rennes, France.
Rennes 1 University, Rennes, France.
JAMA Netw Open. 2022 Jun 1;5(6):e2215209. doi: 10.1001/jamanetworkopen.2022.15209.
Clinical trial data sharing holds promise for maximizing the value of clinical research. The International Committee of Medical Journal Editors (ICMJE) adopted a policy promoting data sharing in July 2018.
To evaluate the association of the ICMJE data sharing policy with data availability and reproducibility of main conclusions among leading surgical journals.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study, conducted in October 2021, examined randomized clinical trials (RCTs) in 10 leading surgical journals before and after the implementation of the ICMJE data sharing policy in July 2018.
Implementation of the ICMJE data sharing policy.
To demonstrate a pre-post increase in data availability from 5% to 25% (α = .05; β = 0.1), 65 RCTs published before and 65 RCTs published after the policy was issued were included, and their data were requested. The primary outcome was data availability (ie, the receipt of sufficient data to enable reanalysis of the primary outcome). When data sharing was available, the primary outcomes reported in the journal articles were reanalyzed to explore reproducibility. The reproducibility features of these studies were detailed.
Data were available for 2 of 65 RCTs (3.1%) published before the ICMJE policy and for 2 of 65 RCTs (3.1%) published after the policy was issued (odds ratio, 1.00; 95% CI, 0.07-14.19; P > .99). A data sharing statement was observed in 11 of 65 RCTs (16.9%) published after the policy vs none before the policy (risk ratio, 2.20; 95% CI, 1.81-2.68; P = .001). Data obtained for reanalysis (n = 4) were not from RCTs published with a data sharing statement. Of the 4 RCTs with available data, all of them had primary outcomes that were fully reproduced. However, discrepancies or inaccuracies that were not associated with study conclusions were identified in 3 RCTs. These concerned the number of patients included in 1 RCT, the management of missing values in another RCT, and discrepant timing for the principal outcome declared in the study registration and reported in the third RCT.
This cross-sectional study suggests that data sharing practices are rare in surgical journals despite the ICMJE policy and that most RCTs published in these journals lack transparency. The results of these studies may not be reproducible by external researchers.
临床试验数据共享有望最大程度地发挥临床研究的价值。国际医学期刊编辑委员会(ICMJE)于 2018 年 7 月出台了一项促进数据共享的政策。
评估 ICMJE 数据共享政策与主要外科期刊中主要结论的数据可用性和可再现性之间的关联。
设计、设置和参与者:这是一项 2021 年 10 月进行的横断面研究,在 2018 年 7 月 ICMJE 数据共享政策实施前后,对 10 种主要外科期刊中的随机对照试验(RCT)进行了调查。
实施 ICMJE 数据共享政策。
证明数据可用性从 5%增加到 25%(α=0.05;β=0.1),纳入了该政策发布前的 65 项 RCT 和发布后的 65 项 RCT,并请求了他们的数据。主要结局是数据可用性(即收到足够的数据以重新分析主要结局)。当数据共享可用时,重新分析了发表在期刊文章中的主要结局,以探索可再现性。详细说明了这些研究的再现性特征。
在 ICMJE 政策发布前,65 项 RCT 中有 2 项(3.1%)的数据可用,而在政策发布后,65 项 RCT 中有 2 项(3.1%)的数据可用(比值比,1.00;95%CI,0.07-14.19;P>.99)。在政策发布后的 65 项 RCT 中有 11 项(16.9%)观察到数据共享声明,而在政策发布前没有(风险比,2.20;95%CI,1.81-2.68;P=.001)。重新分析获得的数据(n=4)并非来自发布数据共享声明的 RCT。在可用数据的 4 项 RCT 中,所有 RCT 的主要结局均完全再现。然而,在 3 项 RCT 中发现了与研究结论无关的差异或不准确之处。这些涉及 1 项 RCT 中纳入的患者数量、另一项 RCT 中缺失值的处理以及在研究注册中声明的主要结局的时间和在第三项 RCT 中报告的时间之间的差异。
这项横断面研究表明,尽管有 ICMJE 政策,但外科期刊的数据共享实践仍然很少,这些期刊中发表的大多数 RCT 缺乏透明度。外部研究人员可能无法再现这些研究的结果。